Clifton NJ 多发性骨髓瘤临床试验
14项针对 多发性骨髓瘤的研究正在 Clifton及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
招募中1/2 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
招募中4 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- Hackensack Meridian Health, Hackensack · 距离 7 英里
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
招募中1 期
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 距离 7 英里
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
招募中2 期
- John Theurer Cancer Center, Hackensack · 距离 7 英里
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
招募中1/2 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 距离 7 英里
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
招募中1/2 期
- Research Site, Hackensack · 距离 7 英里
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
Mosaic Trial for Stem Cell Transplant Recipients
招募中
- Hackensack Meridian Health, Nutley · 距离 3 英里
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
招募中1 期
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 距离 7 英里
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
招募中3 期
- GSK Investigational Site, Hackensack · 距离 7 英里
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
招募中1 期
- Hackensack Meridian John Theurer Cancer Center, Hackensack · 距离 7 英里
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
招募中1/2 期
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 距离 7 英里
其他城市的 多发性骨髓瘤试验
- New York City, NY60 项研究
- Boston, MA42 项研究
- Atlanta, GA41 项研究
- Houston, TX38 项研究
- Durham, NC37 项研究
- Nashville, TN32 项研究
- Denver, CO26 项研究
- Columbus, OH24 项研究
- Rochester, MN24 项研究
- Baldwin Park, CA23 项研究
- St. Louis, MO23 项研究
- Washington, DC22 项研究
Clifton的其他研究
- 非小细胞肺癌24 项研究
- 癌症（所有类型）16 项研究
- 急性髓系白血病13 项研究
- 转移性癌症12 项研究
- 前列腺癌12 项研究
- 乳腺癌12 项研究
- 卵巢癌11 项研究
- 肺癌10 项研究
- 子宫内膜癌9 项研究
- 三阴性乳腺癌8 项研究
- 心力衰竭8 项研究
- 血液癌症8 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。